TScan Therapeutics Competitors and Similar CompaniesClear all

TScan Therapeutics's competitors and similar companies include Fusion Pharmaceuticals, Cullgen and Shoreline Biosciences.

	TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.	Fusion Pharmaceuticals Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer.	Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.	Shoreline Biosciences Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms.
Founding Date	Founding Date 2018	Founding Date 2014	Founding Date 2018	Founding Date 2020
Type	Type Public	Type Subsidiary	Type Private	Type Private
Tags	Tags Technology biotech oncology pharma therapy	Tags Technology biotech oncology pharma therapy	Tags Technology biotech drug development oncology pharma therapy	Tags Technology biotech oncology pharma therapy
Locations	Locations Waltham, US HQ	Locations Hamilton, CA HQ Boston, US	Locations San Diego, US HQ Shanghai, CN Tokyo, JP	Locations San Diego, US HQ San Diego, US
Employees	Employees 7316% increase	Employees 101	Employees 4	Employees 4716% decrease
Financial
Revenue (est.)	Revenue (est.) $10.3m (FY, 2025)	Revenue (est.) $2.1m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($129.8m) (FY, 2025)	Net income ($94.9m) (FY, 2023)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 16m (about 7 years ago)	Latest funding round $ 43m (about 5 years ago)
Total funding raised	Total funding raised $ 137.5m	Total funding raised $ 170.9m	Total funding raised $ 31m	Total funding raised $ 46m